Tetrahydrofuran → HCID 24804444, compound

HRID 2245842Notes

Reaction equation

HRID 2245842 reaction equation
C(OC([C:6]1[N:10]([CH:11]([CH3:13])[CH3:12])[C:9]([C:14]2[C:19]([NH:20][S:21]([C:24]3[CH:29]=[CH:28][C:27]([C:30]([CH3:33])([CH3:32])[CH3:31])=[CH:26][CH:25]=3)(=[O:23])=[O:22])=[CH:18][C:17]([Cl:34])=[CH:16][N:15]=2)=[N:8][N:7]=1)=O)C.[CH3:35][Mg]Br.[CH2:38]1[CH2:42][O:41]CC1>>[C:30]([C:27]1[CH:28]=[CH:29][C:24]([S:21]([NH:20][C:19]2[C:14]([C:9]3[N:10]([CH:11]([CH3:13])[CH3:12])[C:6]([C:42]([OH:41])([CH3:38])[CH3:35])=[N:7][N:8]=3)=[N:15][CH:16]=[C:17]([Cl:34])[CH:18]=2)(=[O:23])=[O:22])=[CH:25][CH:26]=1)([CH3:33])([CH3:32])[CH3:31]

Participants

4

Conditions

Temperature
0 °C

Procedure

A 25 mL scintillation vial was charged with 5-[3-(4-tert-butyl-benzenesulfonylamino)-5-chloro-pyridin-2-yl]-4-isopropyl-4H-[1,2,4]triazole-3-carboxylic acid ethyl ester (prepared according to general procedure B, 11 mg, 0.02 mmol), methylmagnesium bromide in THF (0.2 mL, 3.0 M), and tetrahydrofuran (3 mL). The vial was sealed and stirred at 0° C. for 2 h. The volatiles were then evacuated in vacuo and the residue was purified via preparatory HPLC to afford 4-tert-butyl-N-{5-chloro-2-[5-(1-hydroxy-1-methyl-ethyl)-4-isopropyl-4H-[1,2,4]triazol-3-yl]-pyridin-3-yl}-benzenesulfonamide as a white powder: MS (ES) M+H expected 492.2, found 492.5.

Workup

  1. customThe vial was sealed
  2. customThe volatiles were then evacuated in vacuo
  3. customthe residue was purified via preparatory HPLC

Sources & evidence

ORD record
ord-c3f938b2ec78464e8e3f6246de5f3048
Source dataset
uspto-grants-2010_03
Patent number
US07683176B2

Reaction notes

Loading…